Heart transplantation with marginal recipients and donors

Journal of the Formosan Medical Association

Volumn 98, Issue 10, 1999, Pages 663-667

  Hsu, Ron Bin ^a   Chu, Shu Hsun ^a   Chien, Chen Yen ^a   Chou, Nai Kuan ^a   Chen, Yih Sharng ^a   Ko, Wen Je ^a   Wang, Shoei Shen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Heart transplantation; Marginal donor; Marginal recipient

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; DOPAMINE;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY SIZE; CHILD; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; KIDNEY DISEASE; LIVER DYSFUNCTION; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DONOR; RECIPIENT; RESUSCITATION; SENESCENCE; SURVIVAL RATE; VIRUS CARRIER;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HEART TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; PULMONARY CIRCULATION; SURVIVAL RATE; TISSUE DONORS; VASCULAR RESISTANCE;

EID: 0032745403     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. O'Connell JB, Bristow MR: Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994;13:S107-12.
2. Kahan BD: Immunosuppressive therapy with cyclosporine for cardiac transplantation. Circulation 1987;75:40-56.
3. Sarris GE, Moore KA, Schroeder JS, et al: Cardiac transplantation: the Stanford experience in the cyclosporine era. J Thorac Cardiovasc Surg 1994;108:240-52.
4. McCarthy PM, Starling RC, Wong J, et al: Early results with partial left ventriculectomy. J Thorac Cardiovasc Surg 1997;114:755-65.
5. Chu SH, Wang SS, Tsai CH, et al: Monitoring of two hearts in one chest. J Cardiovasc Surg 1995;36:449-54.
6. Wang SS, Chu SH, Ko WJ, et al: Heterotopic heart transplantation for severe pulmonary hypertension. Transplant Proc 1998;30:3408-9.
7. Wang SS, Chu SH, Ko WJ, et al: Ventricular assist as a bridge to heart transplantation. Transplant Proc 1998;30:3401-2.
8. Hsu RB, Chu SH, Wang SS, et al: Low incidence of transplant coronary artery disease in Chinese heart recipients. J Am Coll Cardiol 1999;33:1573-7.
9. Baldwin JC, Anderson JL, Boucek MM, et al: Taskforce 2: donor guidelines. J Am Coll Cardiol 1993;22:15-20.
10. Kaye MP: The Registry of the International Society for Heart and Lung Transplantation: Tenth Official Report-1993. J Heart Lung Transplant 1993;12:541-8.
11. Hoercher K, Young JB, Stewart RW, et al: Has the use of "marginal" donors increased morbidity and mortality? A single center experience [Abstract]. J Heart Lung Transplant 1998;17:67.
12. Menkis AH, Novick RJ, Kostuk WJ, et al: Successful use of the "unacceptable" heart donor. J Heart Lung Transplant 1991;10:28-32.
13. Kirklin JK, Naftel DC, Kirklin JW, et al: Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 1988;7:331-6.
14. Bourge RC, Kirklin JK, Naftel DC, et al: Analysis and predictors of pulmonary vascular resistance after cardiac transplantation. J Thorac Cardiovasc Surg 1991;101:432-5.
15. Murali S, Uretsky BF, Reddy PS, et al: Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents. Am Heart J 1991;122:1375-81.